Objective: To confirm the psychometrics properties of the Intestinal Gas Questionnaire (IGQ) in subjects with Irritable Bowel Syndrome (IBS) diagnosis and General population both complaining of Gas-Related Symptoms (GRS). IGQ has been developed previously simultaneously in UK English, French and Spanish through qualitative research with subject interviews. The conceptual framework of the IGQ assesses both GRS and their impact on daily life. Similar concepts were identified for both subjects with IBS diagnosis and general population and complaining of gas-related symptoms. The IGQ consists of a 24-hour recall symptom diary assessing 7 gas-related symptoms (17 items) and a 7-day recall questionnaire which assesses the impact of those symptoms (26 items)
Observational (non-interventional) study with a cross-sectional part for a subset of adult subjects with a single IGQ completion and a longitudinal cross-over part for a subset of subjects with test-retest IGQ completion for validation of electronic version of IGQ. 300 eligible subjects (100 in each of the 3 countries: France, UK \& Spain): * 180 with IBS diagnosis (60% of recruited subjects) * 120 from General population (40% of recruited subjects)
Study Type
OBSERVATIONAL
Enrollment
300
Single completion: Participants will have to complete the IGQ, the generic health status EQ-5D questionnaire, the specific FDDQL questionnaire (Functional Digestive Disorders Quality of Life). Test-retest: during the second completion within a mean 7-day interval, participants will complete the IGQ and a single global Gastro-Intestinal Well-Being scale
Hopital Louis Mourier
Colombes, France
Centro de salud Chafarinas
Barcelona, Spain
Horta, Hospital Universitari Vall d'Hebron
Barcelona, Spain
Centre Mèdic Sant Andreu
Barcelona, Spain
Wythenshawe Hospital
Manchester, United Kingdom
Psychometric validation of the IGQ
Stastistical analysis to confirm the psychometric validation of the IGQ questionnaire
Time frame: cross sectional for 70% of participants and test-retest within an interval of 7 days for 30% of participants
Electronic version of the IGQ
Comparison of scores between paper and electronic version of IGQ
Time frame: During test-retest within an interval of 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.